Cargando…

Dehydroabietic Acid Is a Novel Survivin Inhibitor for Gastric Cancer

Gastric cancer is a malignant tumor with a high incidence and mortality rate worldwide. Nevertheless, anticancer drugs that can be used for gastric cancer treatment are limited. Therefore, it is important to develop targeted anticancer drugs for the treatment of gastric cancer. Dehydroabietic acid (...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Won-Jin, Kim, Woong, Bae, Jang-Mi, Gim, Jungsoo, Kim, Seok-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8224772/
https://www.ncbi.nlm.nih.gov/pubmed/34067279
http://dx.doi.org/10.3390/plants10061047

Ejemplares similares